Document is current
Any future updates will be listed below
-
Authors
Mallol, Roger
Rombauts, Alexander
Abelenda-Alonso, Gabriela
Gudiol, Carlota
Balsalobre, Marc
Carratalà, Jordi
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (FI18/00183, CM21/00047, COV20_00121)
Departament de Salut, Generalitat de Catalunya (20DPS005)
- License Information
-
More Information
Article History
Received: 7 April 2024
Accepted: 17 January 2025
First Online: 10 February 2025
Declarations
:
: Roger Mallol owns stock in Biosfer Teslab. The rest of authors declare no competing interests.
: The study was approved by the Bellvitge University Hospital Ethics Committee (PR037/21) in accordance with Spanish legislation, and the procedures followed complied with the ethical standards of the Helsinki Declaration. Written informed consent was obtained for all cases.
